Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EUDA Health Holdings ( (EUDA) ) has provided an update.
On October 20, 2025, EUDA Health Holdings announced that its subsidiary, CK Health Plus, received a Direct Selling License from the Malaysian Ministry of Domestic Trade and Cost of Living. This license enables CK Health Plus to expand its direct selling and multi-level marketing operations in Malaysia, enhancing its network and distribution of wellness products. The approval marks a significant milestone, allowing the company to accelerate its rollout of Bioenergy Capsule Centers and EUDA Helixé supplements, while promoting ethical and educational engagement with customers. This strategic move positions Malaysia as a hub for accessible, science-based longevity solutions, aligning financial success with social impact.
The most recent analyst rating on (EUDA) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on EUDA Health Holdings stock, see the EUDA Stock Forecast page.
More about EUDA Health Holdings
EUDA Health Holdings Limited is a Singapore-based leading non-invasive healthcare provider in Asia, focusing on Singapore, Malaysia, and China. The company aims to lead in non-invasive and preventive healthcare, particularly in the longevity sector, addressing the needs of over 1.8 billion people in a region with a rapidly aging population. EUDA offers innovative, accessible, and science-backed health solutions and also operates a property management business in Singapore.
Average Trading Volume: 117,209
Technical Sentiment Signal: Hold
Current Market Cap: $123.4M
For detailed information about EUDA stock, go to TipRanks’ Stock Analysis page.